Ascentage Pharma Group International (NASDAQ:AAPG) Sets New 1-Year Low - What's Next?

Key Points

• Ascentage Pharma Group International shares fell to a new 52-week low, trading as low as $14.11 and last changing hands at $14.30, below the prior close of $14.88.
• Despite the decline, analyst sentiment remains positive: the stock has an average “Buy” rating and a consensus price target of $43.90, with targets ranging from $33 to $48.
• The company reported a quarterly loss of $0.65 per share on $22.24 million in revenue, and analysts expect a full-year loss of approximately $2.43 per share.

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Friday. The stock traded as low as $14.11 and last traded at $14.30, with a volume of 5,236 shares. The stock had previously closed at $14.88.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on AAPG. William Blair assumed coverage on shares of Ascentage Pharma Group International in a research report on Friday, October 16th. They issued an "outperform" rating for the company. JPMorgan Chase & Co. reduced their price objective on Ascentage Pharma Group International from $46.00 to $33.00 and set an "overweight" rating for the company in a research note on Thursday, October 8th. Citizens Jmp initiated coverage on Ascentage Pharma Group International in a research note on Tuesday, October 13th. They set a "market outperform" rating and a $35.00 target price for the company. BTIG Research reissued a "buy" rating and issued a $48.00 price objective on shares of Ascentage Pharma Group International in a research note on Friday, August 21st. Finally, Citigroup initiated coverage on shares of Ascentage Pharma Group International in a research report on Wednesday, October 14th. They set a "buy" rating and a $46.00 target price on the stock. Two analysts have rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $43.90.

Ascentage Pharma Group International Price Performance

The company has a current ratio of 1.22, a quick ratio of 1.18 and a debt-to-equity ratio of 1.09. The firm's fifty day moving average price is $15.91 and its 200-day moving average price is $20.27.

Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) last posted its quarterly earnings results on Wednesday, August 19th. The company reported ($0.65) earnings per share (EPS) for the quarter. The business had revenue of $22.24 million during the quarter. On average, analysts anticipate that Ascentage Pharma Group International - Unsponsored ADR will post -2.43 earnings per share for the current year.

About Ascentage Pharma Group International

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.